---
figid: PMC6044036__tgh-03-2018.06.04-f2
figlink: /pmc/articles/PMC6044036/figure/f2/
number: Figure 2
caption: Effects of SAM treatment during hepatocarcinogenesis. SAM is involved in
  DNA methylation and stabilization of the DNA repair enzyme APEX1. SAM antioxidant
  activity reduces genomic instability. The inhibition by SAM of LKB1/AMPK axis increases
  cytoplasmic concentration of HuR, which stabilizes p53 and USP7 mRNAs. Through the
  control of the LKB1/AMPK axis, SAM impedes the production of IL6 and cytokines and
  the activation of iNOS and eNOS, thus limiting the oxidative damage. SAM also controls
  cell growth and survival by inducing PPA2 expression that phosphorylates and inactivates
  AKT and its targets. Moreover, PPA2 activation and DUSP1 stabilization inhibit RAS/ERK
  pathway. Finally, SAM affects cell cycle by inhibiting c-MYC expression and polyamine
  synthesis. SAM, S-adenosylmethionine. Adapted with permission from Frau et al.,
  2013.
pmcid: PMC6044036
papertitle: Deregulation of methionine metabolism as determinant of progression and
  prognosis of hepatocellular carcinoma.
reftext: Rosa M. Pascale, et al. Transl Gastroenterol Hepatol. 2018;3:36.
pmc_ranked_result_index: '29807'
pathway_score: 0.9357375
filename: tgh-03-2018.06.04-f2.jpg
figtitle: SAM treatment during hepatocarcinogenesis
year: '2018'
organisms: Homo sapiens
ndex: 2c55ea79-df05-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6044036__tgh-03-2018.06.04-f2.html
  '@type': Dataset
  description: Effects of SAM treatment during hepatocarcinogenesis. SAM is involved
    in DNA methylation and stabilization of the DNA repair enzyme APEX1. SAM antioxidant
    activity reduces genomic instability. The inhibition by SAM of LKB1/AMPK axis
    increases cytoplasmic concentration of HuR, which stabilizes p53 and USP7 mRNAs.
    Through the control of the LKB1/AMPK axis, SAM impedes the production of IL6 and
    cytokines and the activation of iNOS and eNOS, thus limiting the oxidative damage.
    SAM also controls cell growth and survival by inducing PPA2 expression that phosphorylates
    and inactivates AKT and its targets. Moreover, PPA2 activation and DUSP1 stabilization
    inhibit RAS/ERK pathway. Finally, SAM affects cell cycle by inhibiting c-MYC expression
    and polyamine synthesis. SAM, S-adenosylmethionine. Adapted with permission from
    Frau et al., 2013.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - PRKAG3
  - AKT3
  - PRKAB2
  - PRKAG1
  - PRKAB1
  - MAPK3
  - MYC
  - AKT2
  - KRAS
  - PRKAG2
  - PRKAA1
  - HRAS
  - TP53
  - APEX1
  - NRAS
  - NOS3
  - AKT1
  - STK11
  - DUSP1
  - USP7
  - PRKAA2
  - IL6
  - polyamine
  - 'NO'
  - Cancer
genes:
- word: RAS/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: RAS/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MYC,RAS,
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MYC,RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MYC,RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: p53,
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: APEX1
  symbol: APEX1
  source: hgnc_symbol
  hgnc_symbol: APEX1
  entrez: '328'
- word: MYC,RAS,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ENOS,Ä°NOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: LKB1/
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: DUSP1
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: Cyclins,p53,USP7
  symbol: USP7
  source: hgnc_symbol
  hgnc_symbol: USP7
  entrez: '7874'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: IL6,cytokines,
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: polyamine
  source: MESH
  identifier: D011073
- word: 'NO'
  source: ''
  identifier: ''
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
